BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8888085)

  • 1. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR; Rutkowski AF
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review.
    Reeves ST; Turcasso NM
    South Med J; 1997 Aug; 90(8):769-74. PubMed ID: 9258301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blocking agents in the emergency department.
    Rubin MA; Sadovnikoff N
    J Emerg Med; 1996; 14(2):193-9. PubMed ID: 8740751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
    Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL
    Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    Buck ML; Reed MD
    Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):540-5. PubMed ID: 7479211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle relaxants--pancuronium and vecuronium.
    Ball C; Westhorpe RN
    Anaesth Intensive Care; 2006 Apr; 34(2):137. PubMed ID: 16617633
    [No Abstract]   [Full Text] [Related]  

  • 19. Consensus guidelines for sustained neuromuscular blockade in critically ill children.
    Playfor S; Jenkins I; Boyles C; Choonara I; Davies G; Haywood T; Hinson G; Mayer A; Morton N; Ralph T; Wolf A;
    Paediatr Anaesth; 2007 Sep; 17(9):881-7. PubMed ID: 17683408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.